1/155
Looks like no tags are added yet.
What are ophthalmic preparations?
Ophthalmic preparations are sterile products formulated for use in or around the eye.
Common dosage forms in Ophthalmic preparations
Common dosage forms include eye drops, ointments, gels, injections, and implants.
The choice of dosage form depends on the location of the disease and the desired duration of treatment.
Challenges in effective drug delivery in eye
Effective delivery can be challenging because tears, drainage, and ocular barriers limit the amount of drug reaching its target.
dry eye syndrome
Inadequate tear volume or poor tear quality causes ocular surface damage.
May become chronic and difficult to manage, depending on the underlying cause
glaucoma
A group of lifelong diseases causing optic nerve damage and characteristic visual field loss.
whole eye is pushing toward postier side and damaging optic nerve and blood vessels
Age-Related Macular Degeneration (AMD)
Degeneration of the macula causing loss of central vision, usually in adults older than 50 years.
Age-Related Macular Degeneration (AMD) (2 types)
Dry AMD
Wet AMD
Dry AMD
It is more common than wet AMD where retinal pigment epithelium (RPE) degeneration leads to photoreceptor loss and gradual central vision decline.
wet AMD
Abnormal blood vessels beneath the macula leak, causing damage and potentially rapid central vision loss.
Endophthalmitis
Severe inflammation within the eye that can cause permanent vision loss.
Infectious causes of endophthalmitis
Commonly involves Staphylococcus, Streptococcus, or Bacillus species.
Noninfectious causes endophthalmitits
Contaminants or aggregates in intraocular preparations.
opthamic preperation are typically
sterile
3 types of routes for topical ocular drug delivery
topical (corneal) route
intraviteral delivery route
systemic route and blood retinal barrier
topical (corneal) route
the cornea is the main route through which ocular topically administered drugs reach in aqueous humour
intravitreal delivery route
directly delivers drug into the vitreous humor to reach the posterior segment of the eye
systemic route and blood-retinal barrier
the blood retinal barrier (RPE and retinal capillary endothelium) restricts the entry of drugs from the systemic circulation into the posterior segment of the eye
Barriers to Topical Ocular Drug Absorption (4 ways)
tear-protien binding
cornea restrict permeation
lacrimal drainage
conjuctival blood vessels
tear protein binding barrier for eye
reduces free drug avalible for absorption, protien levels increase during inflammation or infection
corena restrict permeation barrier for eye
the cornea limits drug permeation, especially for large, hydrophillic and ionized molecules
lacrimal drainge barrier for eye
removes drug into the nose
conjunctival blood vessels barrier for eye
carry drug inot systemic circulation
eye drops primarly treat
the antieror segment through simple, noninvasive administration
Corneal Layers as Drug Barriers(3 layers)
epithelium
stroma
endothelium
epithelium main characteristics and effect permeation
lipid-rich cells with tight junctions
major barrier to hydrophilic and ionized drugs
stroma main characteristics and effect on permeation
water-rich collage matrix
restricts highly lipophilic and large molecules
endothelium main characteristics and effect permeation
single cell layer with relatively leaky junctions
less restrictive than the epithelium
Drug Properties Favoring Corneal Absorption
Low molecular weight drug generally favors permeation.
Moderate lipophilicity balances passage through the epithelium and aqueous stroma.
A log P of approximately 2–3 favors permeation for the steroids and beta-blockers described.
Excessive lipophilicity with log P > 3 have been shown to have lower permeability due to limited transfer through the stroma.
Good aqueous solubility is important as drugs must be in solution to permeate through the cornea, especially the stroma.
For ionizable drugs, the pH of the formulation can be adjusted to obtain the optimum balance of solubility and transepithelial permeation.
It is desirable for a drug to possess good aqueous solubility at the physiological pH of BLANK , without the loss of lipophilicity for corneal permeation.
tears
Conjunctival blood vessels can carry drug
away from the eye into systemic circulation
which reduces delivery to aquoues humor and may cause systemic adverse effects
Nasolacrimal drainage also allows absorption through the
nasal mucosa, bypassing hepatic first pass metabolism
Advantages of ophthalmic solutions
▪ Ophthalmic solutions are the most common topical ophthalmic
preparation.
▪ They are typically the easiest to manufacture (have the lowest
production cost).
▪ They are relatively easy for a patient or health care provider to
administer.
▪ Ophthalmic solutions are also desirable where a rapid onset of
action is required.
▪ Moreover, solutions are homogeneous and therefore, display a
better dose uniformity
Limitation of Ophthalmic Solution
eye drops are rapidly drained out of the eye
rate of drainage depends on drop size (proportional to size of the drop administered)
limited capacity of conjunctival sac
typical volume form commercial eye dropper bottle per drop is higher than occomadation ammount
the conjunctival sac can only accommodate…
20-30 microliters or added fluid temporally without spilling
typical volume per drop from commercial eye dropper bottles is
34-63 microliters
Addressing the Limitation of Ophthalmic Solution
space different eye drops by at least 5 minutes to minimize washout of the first drop
punctal occlusion to maximize local absorption by closing the eye and gently pressing the inside corner for at least one minute
Why ophthalmic suspensions?
This approach has been used to administer drugs which are sparingly soluble in water (e.g., steroids) or to prolong drug release.
How ophthalmic suspensions provide prolong
drug release?
Particles tend to be retained in the conjunctival sac (pouch where the conjunctiva covering the inside of the lower eyelid and the sclera meet) and slowly go into solution, thus, increasing the contact time
Why particles sized need to be carefully selected in ophthalmic suspensions?
Because some particles can cause irritation of the sensory nerves in the epithelium.
Particle size considerations for an ophthalmic suspension
For a sample containing 10 μg of solid active substance, the European Pharmacopoeia states that
• not more than 20 particles should have a maximum dimension greater than 25 μm
• not more than two of these particles have a maximum dimension greater than 50 μm.
• None of the particles has a maximum dimension greater than 90 μm.
Considerations for Ophthalmic Suspensions: Easy re-dispersibility
The particles of a suspension need to be readily dispersible on shaking by the patient to ensure uniform dose administration.
Considerations for Ophthalmic Suspensions: Avoidance of cake/hard sediment formation
▪ Cake formation can also be a problem, which may not be resolved by forming a flocculated suspension, Since large floccules can irritate the eye.
▪ Using a viscosity-enhancing agent can prevent caking and allow particle resuspension by shaking.
Considerations for Ophthalmic Suspensions: Polymorphic changes of drug particles
▪ One problem that can arise with suspensions is conversion of the crystal structure of the drug
▪ i.e., polymorphic changes during storage, which can lead to changes in drug solubility and dissolution behavior.
Ocular emulsions are submicron
emulsions with droplet size of 200 nm-1mcm
nanoemulsions
droplet size of 50-200 nm
Ocular emulsions are submicron (emulsions with droplet size of 200 nm – 1 μm) or nano- emulsions (emulsions with droplet size of 50 – 200 nm).
• have shown potential for prolonging drug release.
• and achieving significantly higher drug concentrations in the cornea and aqueous humour compared with suspensions.
Ocular emulsions are particularly advantageous for delivering
highly lipohpilic drugs
Advantages of ophthalmic ointments
▪ They offer the advantage of reducing drug drainage by
tear flow, thereby increasing corneal residence time.
▪ Ointments can also be entrapped in the conjunctival sac,
whereby they serve as a reservoir for the drug and
sustained drug release over 2–4 hours is usually
observed.
▪ Ointments also have the advantage of allowing the
incorporation of drugs with poor aqueous solubility.
▪ Hydrophobic ointments sometimes increase the stability
of hydrolysable compounds, particularly peptides.
Limitations of Ophthalmic Ointments
▪ Ointments are, however, more difficult to administer than solutions and may give rise to a more variable dose.
▪ In addition, blurring of vision arises, which tends to reduce patient adherence, making ointments more useful for night-time administration.
▪ Drug molecules may be entrapped within the ointment base because of favorable partitioning towards the base, therefore inhibiting drug release.
What are gels?
▪ Gels, which are semisolid systems comprising water-soluble
bases.
▪ They are more favorable than ointments for water-soluble
drugs.
Polymers used in ophthalmic gels
PVA, poloxamer, hydroxypropyl methylcellulose, carbomers.
Example of ophthalmic gel:
▪ Ganciclovir is an antiviral indicated for herpetic keratitis (eye
ulcers caused by herpes virus which mainly affect the
cornea).
▪ It is available as a gel (Zirgan, Bausch and Lomb) and utilizes
carbomers.
What are In situ ophthalmic gels?
▪ In situ ophthalmic gels are initially formulated as liquids but transform into gels upon instillation into the eye, typically triggered by body temperature, ions or pH.
In simple terms:
• these undergo a phase transition from liquid to solid in the conjunctival sac to form a viscoelastic gel.
Advantage of in situ gels over preformed gels:
As they are administered in liquid form the dose is more reproducible, and administration is easier, thus, improving patient adherence.
Hydrogen ion concentration (pH) consideration for ophthalmic preparations
• The eye can generally tolerate topical ophthalmic preparations at a pH within the range of 3.5 to 9.
• However, it is preferable to formulate preparations as close to physiological tear pH (7.4) as possible to reduce damage and discomfort and the associated increased lacrimation
Isotonicity considerations for ophthalmic preparations
• Isotonicity means that a solution has the same salt (solute) concentration as body fluids, such as tears or blood.
• Body fluids, including blood and tears, have an osmotic pressure corresponding to that of a 0.9% solution of sodium chloride.
• In practice, the isotonicity limits of an ophthalmic solution in terms of sodium chloride or its osmotic equivalent may range from 0.6% to 2% without marked discomfort to the eye.
Surfactants in Ophthalmic Preparations
▪ Surfactants are typically included in ophthalmic preparations to solubilize or disperse drugs.
▪ Nonionic surfactants are the least irritant and therefore the most used.
▪ Examples include polysorbate 20, polyoxyl 40 stearate and polyoxypropylene–polyoxyethylenediol
Why viscosity enhancing polymers are used in ophthalmic preparations?
▪ To reduce the drainage rate.
▪ Thus, prolonging drug retention in the precorneal tear film and enhancing drug absorption.
Acceptable viscosity of the ophthalmic preparations
▪ Acceptable viscosity of ophthalmic preparations is up to 15 mPa.
▪ Beyond that increased lacrimation and drainage occur to restore the tear film to its physiological viscosity.
▪ Furthermore, very viscous solutions can cause blurring of vision, and pain on blinking.
Viscosity Enhancer for Ophthalmic Preparations
▪ Water-soluble polymers that have been used to increase solution viscosity include
• Poly(vinyl alcohol) (PVA)
• Polyvinylpyrrolidone
• Methylcellulose
• Hydroxypropyl methylcellulose
• Carboxymethylcellulose (at
concentrations of 0.2% to 2.5%)
• Polyethylene glycol (at concentrations
of 0.2% to 1%).
Packaging Requirement for Ophthalmic Preparations
▪ Most ophthalmic preparations are packaged in soft plastic
containers with a fixed built-in dropper.
▪ This type of packaging is preferred both to facilitate
administration and to protect the product from external contamination.
▪ Patients must be careful to protect an ophthalmic solution or
suspension from external contamination.
▪ The fixed built-in dropper containers are less likely to
acquire airborne contaminants than screw-type bottles,
which are fully opened when in use
Sterilization of ophthalmic preparations
▪ Ophthalmic solutions and suspensions must be sterilized
for safe use.
▪ It is preferable to sterilize ophthalmics in their final
containers by autoclaving at 121°C (250°F) for 15
minutes.
Disadvantage of autoclaving ophthalmic preparations
This method sometimes is precluded by thermal
instability of the formulation.
Alternative approach to autoclaving ophthalmic preparations
bacterial filiters
Advantage of bacterial filtration over autoclaving ophthalmic preparations
▪ One big advantage of filtration is that it can remove all tiny particles like dust, fibers, alongside microorganisms from a liquid.
▪ This is especially important when making eye drops (ophthalmic solutions), because even very small particles can irritate the eye or cause infection.
Examples of Antimicrobial Preservatives for Ophthalmic
Preparations
Among the antimicrobial preservatives used in ophthalmic
solutions and suspensions and their effective concentrations
are,
• Benzalkonium chloride, 0.004% to 0.01%
• Benzethonium chloride, 0.01%
• Chlorobutanol, 0.5%
• Phenylmercuric acetate, 0.004%
• Phenylmercuric nitrite, 0.004%
• Thimerosal, 0.005% to 0.01%
Prodrugs for Ophthalmic Preparations
▪ A prodrug is a drug with added functionalities that converts to the active parent drug through enzymatic or chemical reactions.
▪ Approaches for enhancing corneal penetration using prodrugs include optimization of lipophilicity.
types of semisolid consistency
ointments, creams, gels, lotions, pastes or plasters
administration route of semisold dosage routes
external application to the skin or mucous membrane such as eye, nose, vagina and rectum
therapeutic effect of semisold dosage forms
local(topical), regional or sytemic
formulation of semisolid dosage forms
one or more active ingredients dissolved or uniformly dispersed in suitable semisolid base and expicents
advantages of semisolid dosage forms
Used externally, direct drug delivery( more bioavailbe)
dosage form tastes bitter (won’t be ingested and deter from ingestion)
More stable than liquid (less hydrolysis reaction)
Can be given to patients who are unconscious or have difficulty swallowing
avoid first pass metabolism
what type of semisolids are most oil and least water soluble to least oil and most water soluble
ointment to cream to gel
olieaginous(hydrocarbon bases)
Oleaginous/ Anhydrous
Greasy, lipophilic
Ointments that contain water-insoluble APIs
occulsive
ex:petrolatum
absoprtion semisolid base
Oleaginous with a water-in-oil (w/o) emulsifying agent
Greasy, but can absorb water
Ointments that can contain water-soluble APIs
Occlusive (but less)
ex: sorbitan sesquioleate
water-removable (water-washable) semisold base
Oil-in-water (o/w) emulsion
Non/less greasy, hydrophilic
Creams that are washable and removable from skin/clothing with water
Non-occlusive
ex: sodium lauryl sulfate
water soluble base for semisolids
No oleaginous components
Greaseless, hydrophilic
Gels that can dissolve water-soluble APIs only, especially solids
Non-occlusive
ex: methylcellulose(gelling agent)
what does occlusive mean
forming a protective seal over the skin because of its oily nature to trap moisture in.
Which types of bases are predominantly (more than 50%) oil?
oleaginous and absoprtion bases
Which type of base would be best suited for a patient with a skin condition associated with dryness?
oleaginous because of its oily and occulisve nature
Which types of bases are capable of dissolving water-soluble APIs?
water-soluble, water removable, absorption
Which type of base can be formed using polymerization?
water souble
which functional groups indicate how a water soluble API can be dissolve by a based
the presence of carboxylic acid and hydroxyl functional group
Gels are
a viscous semi-rigid colloidal system with dispersions of small or large molecules in an aqueous liquid vehicle rendered jellylike by a gelling agent.
At their gelation temperature
gelling agents from a soild 3D network
Gelling agents are often
polymers formed via polymerization of monomeric units.
Monomeric units with gelling agents
nonionic: :cellulose derivatives
anionic
Single-phase system (gels)
no apparent discrete particles, organic macromolecules distributed uniformly throughout a liquid.
how is water readily absorbed by a polymer to form a gel
because of the presence of OH groups or carboxyl groups that are readily absorbed by water
Gels can also be formed using inorganic solids such as aluminum hydroxide or silicon dioxide (colloidal). Inorganic solids are dispersed in the aqueous liquid and form a two-phase gel system (contains small discrete particles). Suggest a reason why these gelling agents form a two-phase system rather than a single phase.
the inorganic solids do not dissociate well in aqueous solutions so it will create the two phase system
imbibition
taking up of a certain amount of liquid by colloid (gel)
either with or without a measurable change in volume. if a measurable volume change occurs, this is called swelling
syneresis
liquid is squeezed out of gel and the gel shrinks while the gel is standing
thixotropy
a reversible gel-sol formation with no change in volume or temperature
gel inot liquid and flows when sheer force is applied but returns to gel state one froce is removed/stopped
aerogel
obtained when the liquid phase of gel is replaced by gas (its solid network is retained)
xerogel
a gel frame remains after the liquid is removed
lotions
Not defined in the USP. Broadly, they are liquid or semi-liquid preparations that contain either none, one, or more APIs.
Emulsions (usually oil-in-water) of very low viscosity (lower viscosity than creams or gels).
Intended to be applied by hand to the unbroken skin.
pastes
Contain one or more drug substances intended for topical application.
Ointments in which large amounts of solids have been incorporated. Concentrates of powders dispersed (usually) in petrolatum or hydrophilic petrolatum.
Treat oozing lesions where they absorb serous secretion and impart some degree of physical protection to the affected area.
plasters
Substances made of such materials and consistency as to adhere to the skin and attach to a dressing.
Forerunners to transdermal drug delivery systems, essentially medicated adhesive dressings/bandages.
Intended to afford protection and support and/or furnish an occlusive action while bringing medication into close contact with the skin
Which type of semisolid base would be necessary to form a plaster?
oleaginous base
How is a paste different than an ointment?
pastes have large amounts of solid